The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone.

Hyperkalemia in patients taking spironolactone for gender transition is rare and when present is transient and asymptomatic. In the absence of other medical comorbidities, routine electrolyte monitoring in this population may be unnecessary.